Last reviewed · How we verify

NCT07465003

Cohort Study of Chronic Liver Disease Complicated by Sepsis

Not yet recruiting Last updated 11 March 2026
What this trial tests

trial in Cirrhosis in 1,600 participants. Not yet recruiting.

Timeline
25 February 2026
Primary endpoint
25 February 2027
1 June 2028

Quick facts

Lead sponsorThe Second Affiliated Hospital of Chongqing Medical University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment1,600
Start date25 February 2026
Primary completion25 February 2027
Estimated completion1 June 2028

Conditions studied

Sponsor

The Second Affiliated Hospital of Chongqing Medical University

Who can join

Eligibility, any sex, with Cirrhosis or Sepsis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study population: Patients with liver cirrhosis complicated by sepsis Observation indicators: Fluid resuscitation strategy, early dynamic indicators such as MAP Observation endpoint: 28-day all-cause mortality Study design: Retrospective cohort study

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cirrhosis

Currently open trials in the same condition.

Other The Second Affiliated Hospital of Chongqing Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07465003.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing